Skip to main content

Articles

1529 result(s) for 'neurology impact factor' within BMC Neurology

Page 31 of 31

  1. Alemtuzumab, a humanized monoclonal antibody directed against the cell surface glycoprotein CD52, is licensed in Europe since October 2013 as treatment for adult patients with active relapsing-remitting multip...

    Authors: Tjalf Ziemssen, Ulrich Engelmann, Sigbert Jahn, Alexandra Leptich, Raimar Kern, Lina Hassoun and Katja Thomas
    Citation: BMC Neurology 2016 16:109
    Content type: Study protocol Published on:

  3. Aging is often associated with behavioral impairments, but some people age more gracefully than others. Why? One factor that may play a role is individual differences in the distinctiveness of neural represent...

    Authors: Holly Gagnon, Molly Simmonite, Kaitlin Cassady, Jordan Chamberlain, Erin Freiburger, Poortata Lalwani, Shannon Kelley, Bradley Foerster, Denise C. Park, Myria Petrou, Rachael D. Seidler, Stephan F. Taylor, Daniel H. Weissman and Thad A. Polk
    Citation: BMC Neurology 2019 19:61
    Content type: Study protocol Published on:

  4. Carotid artery stenosis is a frequent cause of ischemic stroke. While any degree of stenosis can cause embolic stroke, a higher degree of stenosis can also cause hemodynamic infarction. The hemodynamic effect ...

    Authors: Sibu Mundiyanapurath, Peter Arthur Ringleb, Sascha Diatschuk, Oliver Eidel, Sina Burth, Ralf Floca, Markus Möhlenbruch, Wolfgang Wick, Martin Bendszus and Alexander Radbruch
    Citation: BMC Neurology 2016 16:50
    Content type: Research article Published on:

  5. There is increasing evidence for the beneficial effects of exercise training in stroke survivors. In order to reach the desired training effects, exercise training principles must be considered as this ensures...

    Authors: Bernadette C Ammann, Ruud H Knols, Pierrette Baschung, Rob A de Bie and Eling D de Bruin
    Citation: BMC Neurology 2014 14:167
    Content type: Research article Published on:

  6. Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are increasing globally. No disease-modifying therapy are approved for MS pediatric population. Hence, we aim to review the literature o...

    Authors: Raed Alroughani and Alexey Boyko
    Citation: BMC Neurology 2018 18:27
    Content type: Research article Published on:

  7. Recent studies have shown conflicting results regarding the effect of hydrogel coils for treating intracranial aneurysm compared to bare platinum coils. We implemented a meta-analysis to assess the value of hy...

    Authors: Tao Xue, Zhouqing Chen, Weiwei Lin, Jiayi Xu, Xuming Shen and Zhong Wang
    Citation: BMC Neurology 2018 18:167
    Content type: Research article Published on:

  8. Multiple sclerosis (MS) can result in significant mental and physical symptoms, specially muscle weakness, abnormal walking mechanics, balance problems, spasticity, fatigue, cognitive impairment and depression...

    Authors: Farzin Halabchi, Zahra Alizadeh, Mohammad Ali Sahraian and Maryam Abolhasani
    Citation: BMC Neurology 2017 17:185
    Content type: Debate Published on:

  9. Alzheimer’s disease (AD) is the most common type of dementia. International multilateral cost-of-illness (COI) studies have revealed that the cost of treating this disease is huge, which places a significant b...

    Authors: Fangyu Li, Shuoqi Chen, Cuibai Wei and Jianping Jia
    Citation: BMC Neurology 2017 17:15
    Content type: Research article Published on:

  10. Administrative healthcare claims data provide a mechanism for assessing and monitoring multiple sclerosis (MS) disease status across large, clinically representative “real-world” populations. The estimation of...

    Authors: Michael Munsell, Molly Frean, Joseph Menzin and Amy L. Phillips
    Citation: BMC Neurology 2017 17:106
    Content type: Research article Published on:

  11. Rapidly determining the causes of a depressed level of consciousness (DLOC) including coma is a common clinical challenge. Quantitative analysis of the electroencephalogram (EEG) has the potential to improve D...

    Authors: MohammadMehdi Kafashan, Shoko Ryu, Mitchell J. Hargis, Osvaldo Laurido-Soto, Debra E. Roberts, Akshay Thontakudi, Lawrence Eisenman, Terrance T. Kummer and ShiNung Ching
    Citation: BMC Neurology 2017 17:197
    Content type: Technical advance Published on:

  13. Although patients with dementia frequently experience neuropsychological symptoms (NPS) such as agitation, which profoundly impacts patients, caregivers, and the healthcare system, few studies have evaluated t...

    Authors: Myrlene Sanon Aigbogun, Robert Stellhorn, Ann Hartry, Ross A. Baker and Howard Fillit
    Citation: BMC Neurology 2019 19:33
    Content type: Research article Published on:

  14. About 30% of stroke patients suffer from aphasia. As aphasia strongly affects daily life, most patients request a prediction of outcome of their language function. Prognostic models provide predictions of outc...

    Authors: Femke Nouwens, Evy G. Visch-Brink, Hanane El Hachioui, Hester F. Lingsma, Mieke W. M. E. van de Sandt-Koenderman, Diederik W. J. Dippel, Peter J. Koudstaal and Lonneke M. L. de Lau
    Citation: BMC Neurology 2018 18:170
    Content type: Research article Published on:

  15. The 10-Meter Walk Tests (10MWT) and the 6-Minute Walk Test (6MinWT) are applied to assess gait capacity in paediatric patients. To better objectify changes in qualitative aspects of gait, temporo-spatial param...

    Authors: Judith V. Graser, Claudia Letsch and Hubertus J. A. van Hedel
    Citation: BMC Neurology 2016 16:15
    Content type: Research article Published on:

  17. Living with a chronic condition such as epilepsy can have a debilitating effect on the individual and their carers. Managing epilepsy among people with learning disabilities may present a challenge because of ...

    Authors: Jerry Paul K. Ninnoni
    Citation: BMC Neurology 2019 19:12
    Content type: Research article Published on:

  18. Currently, it is challenging to detect the awareness of patients who suffer disorders of consciousness (DOC). Brain-computer interfaces (BCIs), which do not depend on the behavioral response of patients, may s...

    Authors: Qiuyou Xie, Jiahui Pan, Yan Chen, Yanbin He, Xiaoxiao Ni, Jiechun Zhang, Fei Wang, Yuanqing Li and Ronghao Yu
    Citation: BMC Neurology 2018 18:144
    Content type: Research article Published on:

  19. Delayed-release dimethyl fumarate (DMF) has demonstrated efficacy and a favorable benefit-risk profile in phase 2 and 3 studies that enrolled predominantly white patients with relapsing-remitting multiple scle...

    Authors: Takahiko Saida, Takashi Yamamura, Takayuki Kondo, Jang Yun, Minhua Yang, Jie Li, Lalitha Mahadavan, Bing Zhu and Sarah I. Sheikh
    Citation: BMC Neurology 2019 19:5
    Content type: Research article Published on:

  20. There is emerging research detailing the relationship between balance/gait/falls and cognition. Imaging studies also suggest a link between structural and functional changes in the frontal lobe (a region commo...

    Authors: LA King, DS Peterson, M. Mancini, P. Carlson-Kuhta, BW Fling, K. Smulders, JG Nutt, M. Dale, J. Carter, KM Winters-Stone and FB Horak
    Citation: BMC Neurology 2015 15:218
    Content type: Study protocol Published on:

  21. Interferon (IFN) beta drugs have been approved for the treatment of relapsing forms of multiple sclerosis (RMS) for more than 20 years and are considered to offer a favourable benefit-risk profile. In July 201...

    Authors: Annette Kolb-Mäurer, Cord Sunderkötter, Borries Kukowski and Sven G. Meuth
    Citation: BMC Neurology 2019 19:130
    Content type: Debate Published on:

  22. Subcutaneous peginterferon beta-1a has previously been shown to reduce the number of T2-hyperintense and gadolinium-enhancing (Gd+) lesions over 2 years in patients with relapsing-remitting multiple sclerosis ...

    Authors: Douglas L. Arnold, Peter A. Calabresi, Bernd C. Kieseier, Shifang Liu, Xiaojun You, Damian Fiore and Serena Hung
    Citation: BMC Neurology 2017 17:29
    Content type: Research article Published on:

  23. Intermittent theta burst stimulation (iTBS) is a form of repetitive transcranial stimulation that has been used to enhance upper limb (UL) motor recovery. However, only limited studies have examined its effica...

    Authors: Yu-Jen Chen, Ying-Zu Huang, Chung-Yao Chen, Chia-Ling Chen, Hsieh-Ching Chen, Ching-Yi Wu, Keh-Chung Lin and Tzu-ling Chang
    Citation: BMC Neurology 2019 19:69
    Content type: Research article Published on:

  24. We aimed to determine whether early statin use following recanalization therapy improves the functional outcome of ischemic stroke.

    Authors: Jihoon Kang, Nayoung Kim, Tae Hwan Park, Oh Young Bang, Ji Sung Lee, Juneyoung Lee, Moon-Ku Han, Seong-Ho Park, Philip B. Gorelick and Hee-Joon Bae
    Citation: BMC Neurology 2015 15:122
    Content type: Research article Published on:

  25. Active Rehabilitation (AR) is a community peer-based concept for people with spinal cord injury (SCI) that is primarily delivered through brief residential training programmes. Despite a plethora of positive a...

    Authors: Anestis Divanoglou, Tomasz Tasiemski and Sophie Jörgensen
    Citation: BMC Neurology 2020 20:14
    Content type: Study protocol Published on:

  26. Exercise has failed to reduce falls in those with chronic stroke. A limitation of traditional exercise is that the motor responses needed to prevent a fall are not elicited (i.e. they lack processing specificity)...

    Authors: Jamie Pigman, Darcy S. Reisman, Ryan T. Pohlig, Tamara R. Wright and Jeremy R. Crenshaw
    Citation: BMC Neurology 2019 19:102
    Content type: Research article Published on:

  27. Up to half of all people with HIV infection have some degree of cognitive impairment. This impairment is typically mild, but nonetheless often disabling. Although early detection of cognitive impairment offers...

    Authors: Marie-Josée Brouillette, Lesley K. Fellows, Lisa Palladini, Lois Finch, Réjean Thomas and Nancy E. Mayo
    Citation: BMC Neurology 2015 15:224
    Content type: Research article Published on:

  28. Disease-modification clinical trials in neurodegenerative disorders have struggled to separate symptomatic effects of putative agents from disease-modification. In response, a variety of clinical trial designs...

    Authors: David J. M. McGhee, Craig W. Ritchie, John P. Zajicek and Carl E. Counsell
    Citation: BMC Neurology 2016 16:92
    Content type: Research article Published on:

  29. Cerebral amyloid angiopathy (CAA) refers to the deposition of β-amyloid (Aβ) peptides in the wall of brain vasculature, commonly involving capillaries and arterioles. Also being considered a part of CAA is the...

    Authors: Zhi-Qin Xue, Zheng-Wen He, Jian-Jun Yu, Yan Cai, Wen-Ying Qiu, Aihua Pan, Wei-Ping Gai, Huaibin Cai, Xue-Gang Luo, Chao Ma and Xiao-Xin Yan
    Citation: BMC Neurology 2015 15:71
    Content type: Research article Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    2.6 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    1.092 - SNIP (Source Normalized Impact per Paper)
    0.771 - SJR (SCImago Journal Rank)

    2023 Speed
    26 days submission to first editorial decision for all manuscripts (Median)
    154 days submission to accept (Median)

    2023 Usage 
    3,186,031 downloads
    2,601 Altmetric mentions 

Follow

Sign up for article alerts and news from this journal

BMC Neurology

ISSN: 1471-2377

Contact us